551
Participants
Start Date
September 24, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
13-valent pneumococcal conjugate vaccine (13vPnC)
0.5 mL per dose, 4 doses
diphtheria, tetanus, and acellular pertussis vaccine (DTaP)
0.5 mL per dose, 4 doses
7-valent pneumococcal conjugate vaccine (7vPnC)
0.5 mL per dose, 4 doses
DTaP
0.5 mL per dose, 4 doses
DTaP
0.5 mL per dose, 4 doses
Sunrise Children's Clinic, Funabashi
Sotobo Children's Clinic, Isumi
Matsuyama Red Cross Hospital, Matsuyama
Fukazawa Pediatric Clinic, Higashi-ku, Fukuoka-city
National Hospital Organization Fukuyama Medical Center, Fukuyama
National Hospital Organization Kure Medical Center, Kure
Nakata pediatric clinic, Sapporo
Watanabe Pediatric Allergy Clinic, Sapporo
Furuta Children's Clinic, Sapporo
Motomachi pediatric clinic, Sapporo
Tenshi Hospital, Sapporo
Yoshimoto Pediatrist Clinic, Kikuchi-gun
Shiroko Clinic, Suzuka
National Mie Hospital, Tsu
National hospital Organization Mie Chuou Medical Center, Tsu
Children's Enomoto Clinic, Kumagaya
Shibuya Clinic, Kumagaya
Sakiyama Children's Clinic, Fuchū
Okawa Children and Family Clinic, Ōta-ku
Seijo Sasamoto Pediatric And Allergy Clinic, Setagaya-ku
National Center for Child Health and Development, Setagaya-ku
Miyata Pediatric Clinic, Tachikawa-shi
Maehara Pediatric Clinic, Tama
Childrens Clinic of Kose, Kofu
Medical Corporation Bunpoukai Amemiya Clinic, Koushu-shi
Medical Corporation Seijinkai Takei Clinic, Tsuru-shi
National Hospital Organization Fukuoka National Hospital, Fukuoka
Harada Clinic, Fukuoka
Hattori Pediatric Clinic, Kumamoto
Medical Corporation Seiaikai Seguchi Pediatric Clinic, Kumamoto
Medical Corporation Oukakai Sakuranbo Kodomo Clinic, Kumamoto
Momotaro Clinic, Okayama
Lead Sponsor
Pfizer
INDUSTRY